Mark L. Bernstein
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
Papers in
- Neurology 30
- Neuroblastoma Research and Treatments 28
-
- Sarcoma Diagnosis and Treatment 29
- Co-authors
- Mark Krailo (29 shared papers)Susan M. Blaney (24 shared papers)Holcombe E. Grier (17 shared papers)Michael B. Harris (6 shared papers)Mark C. Gebhardt (9 shared papers)Allen M. Goorin (9 shared papers)Neyssa M. Marina (17 shared papers)John Moreland (1 shared paper)
- Journals
- Journal of Clinical Oncology (24 papers)Pediatric Blood & Cancer (17 papers)Journal of Pediatric Hematology/Oncology (13 papers)Cancer (10 papers)Cancer Chemotherapy and Pharmacology (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark L. Bernstein
185 papers receiving 10.8k citations
Mark L. Bernstein's Hit Papers
Peers
Comparison fields: 5 of 151
- Pulmonary and Respiratory Medicine 4.5k
- Neurology 1.7k
- Oncology 2.2k
- Rheumatology 1.1k
- Cancer Research 1.0k
Countries citing papers authored by Mark L. Bernstein
This map shows the geographic impact of Mark L. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Bernstein more than expected).
Fields of papers citing papers by Mark L. Bernstein
This network shows the impact of papers produced by Mark L. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Bernstein. The network helps show where Mark L. Bernstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark L. Bernstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate Hit paper breakdown → | 2005 | 613 |
| 2 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group Hit paper breakdown → | 2008 | 606 |
| 3 | Ewing Sarcoma: Current Management and Future Approaches Through Collaboration Hit paper breakdown → | 2015 | 514 |
| 4 | Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Hit paper breakdown → | 2019 | 490 |
| 5 | Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Hit paper breakdown → | 2016 | 400 |
| 6 | 2006 | 374 | |
| 7 | Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial Hit paper breakdown → | 2015 | 347 |
| 8 | 2002 | 269 | |
| 9 | 2009 | 264 | |
| 10 | 2001 | 261 | |
| 11 | 2014 | 259 | |
| 12 | 2005 | 257 | |
| 13 | 2012 | 204 | |
| 14 | 2004 | 200 | |
| 15 | 1996 | 184 | |
| 16 | 2007 | 184 | |
| 17 | Absence of p53 gene mutations in primary neuroblastomas. | 1993 | 176 |
| 18 | Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. | 2003 | 171 |
| 19 | 1995 | 167 | |
| 20 | 2007 | 162 |
About Mark L. Bernstein
Mark L. Bernstein is a scholar working on Neurology, Pulmonary and Respiratory Medicine, Hematology, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 187 papers that have together received 11.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (29 papers), Neuroblastoma Research and Treatments (28 papers), Acute Lymphoblastic Leukemia research (14 papers), Childhood Cancer Survivors' Quality of Life (13 papers), Cancer therapeutics and mechanisms (10 papers), Oral and Maxillofacial Pathology (9 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Oral Health Pathology and Treatment (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.5k citations), Neurology (1.7k citations), Oncology (2.2k citations), Rheumatology (1.1k citations) and Cancer Research (1.0k citations). Mark L. Bernstein has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Mark Krailo, Susan M. Blaney, Holcombe E. Grier, Michael B. Harris, Mark C. Gebhardt, Allen M. Goorin, Neyssa M. Marina, John Moreland, Meenakshi Devidas and Richard L. Momparler. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Journal of Pediatric Hematology/Oncology, Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.